0001562180-19-003669.txt : 20190627
0001562180-19-003669.hdr.sgml : 20190627
20190627165331
ACCESSION NUMBER: 0001562180-19-003669
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190625
FILED AS OF DATE: 20190627
DATE AS OF CHANGE: 20190627
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROGERS MICHAEL W
CENTRAL INDEX KEY: 0001244159
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51122
FILM NUMBER: 19926010
MAIL ADDRESS:
STREET 1: C/O KERYX BIOPHARMACEUTICALS INC
STREET 2: ONE MARINA PARK DRIVE
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EyePoint Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001314102
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 262774444
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 480 PLEASANT STREET
STREET 2: SUITE B300
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617-926-5000
MAIL ADDRESS:
STREET 1: 480 PLEASANT STREET
STREET 2: SUITE B300
CITY: WATERTOWN
STATE: MA
ZIP: 02472
FORMER COMPANY:
FORMER CONFORMED NAME: pSivida Corp.
DATE OF NAME CHANGE: 20080619
FORMER COMPANY:
FORMER CONFORMED NAME: pSivida LTD
DATE OF NAME CHANGE: 20050111
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2019-06-25
true
0001314102
EyePoint Pharmaceuticals, Inc.
EYPT
0001244159
ROGERS MICHAEL W
C/O EYEPOINT PHARMACEUTICALS, INC.
480 PLEASANT STREET
WATERTOWN
MA
02472
true
false
false
false
Stock Option (Right to Buy)
2.65
2019-06-25
4
A
false
40000.00
0.00
A
2019-06-25
2020-06-25
Common Stock
40000.00
40000.00
D
Reflects the closing price of the Company's common stock on February 21, 2019, which was the date the option grant was approved by the Compensation Committee of the Board of Directors (the "Committee") of EyePoint Pharmaceuticals, Inc. (the "Registrant"), subject to stockholder approval of an amendment to the Registrant's 2016 Long Term Incentive Plan (the "Plan Amendment").
The option grant was approved by the Committee on February 21, 2019, subject to stockholder approval of the Plan Amendment. The Registrant's stockholders approved the Plan Amendment on June 25, 2019.
The option to purchase, which vested immediately upon Mr. Rogers' departure from the Board, will be exercisable until June 25, 2020
/s/ John Mercer, Attorney-in-Fact
2019-06-27